While p‐tau181 and its ratio with Aβ42 were the best markers to detect AD along its continuum, NfL and GFAP had stronger performance to identify DLB and FTD, specifically where there was no amyloid co‐pathology. The gene discussed is NEFL; the disease is Lewy body dementia.